Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | THRB | P10828 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 2/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6281191 | 1.00 | TSHR (0.63) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL14658115 | 1.00 | TSHR (0.63) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL9011548 | 1.00 | TSHR (0.63) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL10950022 | 1.00 | TSHR (0.63) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL9011718 | 1.00 | TSHR (0.63) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL199075 | 0.97 | THRB (0.67) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL199223 | 0.97 | THRB (0.67) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL20842523 | 0.97 | THRB (0.67) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL199279 | 0.97 | THRB (0.67) | TSHRTHRBHTTMEN1KMT2A | |
| SCHEMBL127318 | 0.97 | THRB (0.67) | TSHRTHRBHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111440132-B | Novel method for preparing oxygen heterocyclic compound by ionic liquid catalysis | 中国科学院化学研究所 | 2022-02-01 | — | — | CN | claimed |
| CN-111440132-A | Novel method for preparing oxygen heterocyclic compound by ionic liquid catalysis | 中国科学院化学研究所 | 2020-07-24 | — | — | CN | claimed |
| US-20230398226-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-12-14 | — | — | US | disclosed |
| US-11833213-B2 | Compositions and methods for the treatment of viral infections | CIDARA THERAPEUTICS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| CN-111440132-B | Novel method for preparing oxygen heterocyclic compound by ionic liquid catalysis | 中国科学院化学研究所 | 2022-02-01 | — | — | CN | disclosed |
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| CN-111440132-A | Novel method for preparing oxygen heterocyclic compound by ionic liquid catalysis | 中国科学院化学研究所 | 2020-07-24 | — | — | CN | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9334371-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| US-9309481-B2 | Lubricant composition | IDEMITSU KOSAN CO., LTD. (JP) | 2016-04-12 | — | — | US | disclosed |
| EP-2735581-A1 | COMPOSITION AND POLYMER | Asahi Kasei Chemicals Corporation (JP) | 2014-05-28 | — | — | EP | disclosed |
| US-20140121293-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-20130005624-A1 | LUBRICANT COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| US-5529874-A | ETHER CARRIER LIQUID AND TONER PARTICLES DISPERSED THEREIN; SUITABLE FOR HIGH SPEED COPYING | FUJI XEROX CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398226-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | FCGR3B, ALB, FCGR1A | TSHR 2184/4885THRB 2870/4885HTT 4145/4885 |
| US-11833213-B2 | Compositions and methods for the treatment of viral infections | FCGR3B, ALB, FCGR1A | TSHR 2184/4885THRB 2870/4885HTT 4145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.